Laparoscopic myomectomy in a single centre over 10 years: a retrospective study

Mei Yun Chan; Yau Bong Winsom Ho

doi:10.12809/hkjgom.24.1.351

Authors

Mei Yun Chan United Christian Hospital
Yau Bong Winsom Ho United Christian Hospital

DOI:

https://doi.org/10.12809/hkjgom.24.1.351

Keywords:

Laparoscopic myomectomy, Leiomyoma, Morcellation, Myomectomy

Abstract

Introduction: We retrospectively reviewed medical records of patients who underwent laparoscopic myomectomy in a hospital in Hong Kong over a period of 10 years.
Methods: Medical records of women who underwent laparoscopic myomectomy at the United Christian Hospital between January 2012 and December 2021 were retrospectively reviewed. Outcomes were compared between patients with fibroids >8 cm and patients with fibroids ≤8 cm and between patients with fibroids at the broad ligament or low positions and patients with fibroids at common locations.
Results: A total of 225 women aged 25 to 56 years were identified and a total of 460 fibroids were removed. Of 225 women, 47 (20.9%) had a fibroid >8 cm, whereas 17 (3.7%) had a fibroid at the broad ligament or low positions. Intraoperative complications included subcutaneous emphysema (n=3), breakage of the bag during contained power morcellation (n=1), and blood loss of 1400 ml (n=2). Postoperative complications included fever (n=4), wound infection with gaping (n=3), and pelvic haematoma (n=1). The rate of complication was 6.22%, and the rate of major complication was 2.22%. The rate of undiagnosed uterine malignancy was 0.4%. Compared with patients with fibroids ≤8 cm, patients with fibroids >8 cm had higher blood loss (161.56 vs 265.96 ml, p=0.029), operating time (145.44 vs 183.30 min, p=0.002), and intraoperative complications (1 vs 5, p<0.001). However, patients with fibroids at common locations were comparable with patients with fibroids at the broad ligament or low positions in terms of blood loss, operating time, inpatient stay, and intraoperative and postoperative complications.
Conclusions: Laparoscopic myomectomy is safe for fibroids >8 cm or at the broad ligament or low positions.

References

Amoah A, Joseph N, Reap S, Quinn SD. Appraisal of national and international uterine fibroid management guidelines: a systematic review. BJOG 2022;129:356-64.

Jin C, Hu Y, Chen XC, et al. Laparoscopic versus open myomectomy: a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 2009;145:14-21.

Mallick R, Odejinmi F. Pushing the boundaries of laparoscopic myomectomy: a comparative analysis for peri-operative outcomes in 323 women undergoing laparoscopic myomectomy in a tertiary referral centre. Gynecol Surg 2017;14:22.

Food and Drug Administration. FDA updated assessment of the use of laparoscopic power morcellators to treat uterine fibroids. Accessed 18 August 2023. Available from: www.fda.gov/media/109018/download.

Bean EM, Cutner A, Holland T, Vashisht A, Jurkovic D, Saridogan E. Laparoscopic myomectomy: a single-center retrospective review of 514 patients. J Minim Invasive Gynecol 2017;24:485-93.

Bryant-Smith A, Holland T. Laparoscopic myomectomy: a review of alternatives, techniques and controversies. Obstet Gynaecol 2018;20:261-8.

Ludovisi M, Moro F, Pasciuto T, et al. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma. Ultrasound Obstet Gynecol 2019;54:676-87.

British Society for Gynaecological Endoscopy. BSGE statement on power morcellation. Accessed 18 August 2023. Available from: www.bsge.org.uk/news/bsge-statementpower-morcellation.

Brohl AS, Li I, Andikyan V, et al. Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma. Oncologist 2015;20:433-9.

Lynam S, Young L, Morozov V, Rao G, Roque DM. Risk, risk reduction and management of occult malignancy diagnosed after uterine morcellation: a commentary. Womens Health (Lond) 2015;11:929-44.

Ott DE. Subcutaneous emphysema--beyond the pneumoperitoneum. JSLS 2014;18:1-7.